These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 9920138

  • 1. Carbohydrate and lipid metabolism during various growth hormone dosing regimens in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A, de Muinck Keizer-Schrama SM, Aanstoot HJ, Stijnen T, Hoogerbrugge N, Drop SL.
    Metabolism; 1999 Jan; 48(1):7-14. PubMed ID: 9920138
    [Abstract] [Full Text] [Related]

  • 2. Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study. Dutch Advisory Group on Growth Hormone.
    Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Aanstoot HJ, Drop SL.
    J Clin Endocrinol Metab; 2000 Feb; 85(2):769-75. PubMed ID: 10690889
    [Abstract] [Full Text] [Related]

  • 3. Carbohydrate metabolism during growth hormone treatment and after discontinuation of growth hormone treatment in girls with Turner syndrome treated with once or twice daily growth hormone injections.
    Sas T, de Muinck Keizer-Schrama S, Aanstoot HJ, Stijnen T, Drop S.
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):741-7. PubMed ID: 10848879
    [Abstract] [Full Text] [Related]

  • 4. Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome.
    Van Pareren YK, De Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Drop SL.
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5442-8. PubMed ID: 12466334
    [Abstract] [Full Text] [Related]

  • 5. Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome. (Dutch Working Group on Growth Hormone).
    van Teunenbroek A, de Muinck Keizer-Schrama S, Stijnen T, Waelkens J, Wit JM, Vulsma T, Gerver WJ, Reeser H, Delemarre-van de Waal H, Jansen M, Drop S.
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):451-9. PubMed ID: 9196608
    [Abstract] [Full Text] [Related]

  • 6. Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age.
    Sas T, Mulder P, Aanstoot HJ, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A.
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):243-51. PubMed ID: 11207640
    [Abstract] [Full Text] [Related]

  • 7. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH, Naeraa RW, Brixen K, Kastrup KW, Mosekilde L, Jørgensen JO, Christiansen JS.
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [Abstract] [Full Text] [Related]

  • 8. Carbohydrate and lipid metabolism in Turner syndrome: effect of therapy with growth hormone, oxandrolone, and a combination of both.
    Wilson DM, Frane JW, Sherman B, Johanson AJ, Hintz RL, Rosenfeld RG.
    J Pediatr; 1988 Feb; 112(2):210-7. PubMed ID: 3276862
    [Abstract] [Full Text] [Related]

  • 9. A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial.
    Sass TC, De Muinck Keizer-Schrama SM, Stijnen T, Asarfi A, Van Leeuwen WJ, Van Teunenbroek A, Van Rijn RR, Drop SL.
    Clin Endocrinol (Oxf); 2000 May; 52(5):531-6. PubMed ID: 10792330
    [Abstract] [Full Text] [Related]

  • 10. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Delemarre-van de Waal HA, Vulsma T, Wit JM, Rouwé CW, Reeser HM, Gosen JJ, Rongen-Westerlaken C, Drop SL.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
    [Abstract] [Full Text] [Related]

  • 11. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
    Florakis D, Hung V, Kaltsas G, Coyte D, Jenkins PJ, Chew SL, Grossman AB, Besser GM, Monson JP.
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):453-9. PubMed ID: 11012570
    [Abstract] [Full Text] [Related]

  • 12. Components of the metabolic syndrome in girls with Turner syndrome treated with growth hormone in a long term prospective study.
    Błaszczyk E, Shulhai AM, Gieburowska J, Barański K, Gawlik AM.
    Front Endocrinol (Lausanne); 2023 Oct; 14():1216464. PubMed ID: 37497348
    [Abstract] [Full Text] [Related]

  • 13. Dose-dependent effect of growth hormone therapy on glucose metabolism in subjects with Turner syndrome. The German Lilly Ullrich-Turner Syndrome Study Group.
    Weise M, James D, Hartmann KH, Reinhardt D, Leitner C, Böhles HJ, Attanasio A.
    Horm Res; 1993 Oct; 39 Suppl 2():25-9. PubMed ID: 8359785
    [Abstract] [Full Text] [Related]

  • 14. Effect of oxandrolone on glucose metabolism in growth hormone-treated girls with Turner syndrome.
    Menke LA, Sas TC, Stijnen T, Zandwijken GR, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM.
    Horm Res Paediatr; 2011 Feb; 75(2):115-22. PubMed ID: 20814189
    [Abstract] [Full Text] [Related]

  • 15. The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.
    Beshyah SA, Henderson A, Niththyananthan R, Skinner E, Anyaoku V, Richmond W, Sharp P, Johnston DG.
    J Clin Endocrinol Metab; 1995 Feb; 80(2):356-63. PubMed ID: 7852490
    [Abstract] [Full Text] [Related]

  • 16. Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with turner syndrome.
    Mauras N, Shulman D, Hsiang HY, Balagopal P, Welch S.
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4154-60. PubMed ID: 17711924
    [Abstract] [Full Text] [Related]

  • 17. Glucose metabolism in Ullrich Turner syndrome: long-term effects of therapy with human growth hormone. German Lilly UTS Study Group.
    Weise M, James D, Leitner CH, Hartmann KK, Böhles HJ, Attanasio A.
    Horm Res; 1993 Nov; 39(1-2):36-41. PubMed ID: 8406337
    [Abstract] [Full Text] [Related]

  • 18. Small for gestational age (SGA): endocrine and metabolic consequences and effects of growth hormone treatment.
    Hokken-Koelega AC, De Waal WJ, Sas TC, Van Pareren Y, Arends NJ.
    J Pediatr Endocrinol Metab; 2004 Mar; 17 Suppl 3():463-9. PubMed ID: 15134308
    [Abstract] [Full Text] [Related]

  • 19. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
    Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, van Teunenbroek A, Hokken-Koelega AC, Waelkens JJ, Massa GG, Vulsma T, Gerver WJ, Reeser HM, Delemarre-van de Waal HE, Jansen M, Drop SL.
    Arch Dis Child; 1999 Jan; 80(1):36-41. PubMed ID: 10325756
    [Abstract] [Full Text] [Related]

  • 20. Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A, de Muinck Keizer-Schrama SM, Stijnen T, Mouton JW, Blum WF, Mercado M, Baumann G, Drop SL.
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):77-84. PubMed ID: 7688672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.